Compare GSK plc (GSK) vs LYFT Inc (LYFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs LYFT Inc — how do they compare? GSK plc trades at $50.58 (market cap $102.60B), while LYFT Inc trades at $17.5 (market cap $6.64B). The key difference: GSK plc is far larger — about 15.5× LYFT Inc's market cap, and GSK plc pays a 3.57% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| GSK | LYFT | |
|---|---|---|
Market Cap | $102.60B | $6.64B |
Sector | Health | Industrials |
52-Week High | $61.18 | $24.57 |
52-Week Low | $38.22 | $12.65 |
Enterprise Value | $123.04B | $6.11B |
Dividend Yield | 3.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
